Northern Trust
RAIN

Northern Trust’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Northern Trust’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-115,856
Closed -$139K – 4542
2023
Q4 		$139K Buy
115,856
+24,708
+27% +$26.7K ﹤0.01% 4025
2023
Q3 		$78.6K Sell
91,148
-35,845
-28% -$39.3K ﹤0.01% 4064
2023
Q2 		$152K Buy
126,993
+99,401
+360% +$497K ﹤0.01% 3919
2023
Q1 		$241K Buy
27,592
+12,896
+88% +$119K ﹤0.01% 3773
2022
Q4 		$118K Buy
14,696
+1,381
+10% +$8.67K ﹤0.01% 4042
2022
Q3 		$65K Sell
13,315
-1,215
-8% -$7.63K ﹤0.01% 4250
2022
Q2 		$80K Sell
14,530
-107,294
-88% -$368K ﹤0.01% 4264
2022
Q1 		$618K Buy
121,824
+49,727
+69% +$399K ﹤0.01% 3653
2021
Q4 		$929K Buy
72,097
+2,404
+3% +$34.3K ﹤0.01% 3570
2021
Q3 		$1.04M Sell
69,693
-6,579
-9% -$112K ﹤0.01% 3537
2021
Q2 		$1.19M Buy
+76,272
New +$1.34M ﹤0.01% 3491

Northern Trust's RAIN Position: Q1 2024 in Review

Northern Trust sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 115,856 shares — an estimated $139K sold.

Northern Trust first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $1.19M in Q2 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

  • Northern Trust reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Northern Trust sold 115,856 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $139K.
  • Northern Trust first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Northern Trust's Rain Oncology Inc. Common Stock position peaked at $1.19M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.